secwatch.observer — SEC 8-K summary
======================================

Issuer:     Corbus Pharmaceuticals Holdings, Inc. (CRBP)
CIK:        0001595097
Form:       8-K
Filed at:   2025-03-21T23:59:59+00:00
Accession:  0000950170-25-043276
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Peter Salzmann not standing for re-election; board size reduced to seven
--------------------------------------------------------------------------------

- Dr. Salzmann will not stand for re-election at the 2025 annual meeting.
- He continues as director and Nominating and Governance Committee member until the meeting.
- Decision was not due to any disagreement with the company.
- Board size reduced from eight to seven effective after the annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1595097/000095017025043276/0000950170-25-043276-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1595097/000095017025043276/crbp-20250320.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-043276

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer